Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

× No keyword cloud information.

7 in total

Review 1. Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.

Authors: Jürgen Beer; Claudia Christina Wagner; Markus Zeitlinger
Journal: AAPS J Date: 2009-01-01 Impact factor: 4.009

Review 2. Protein binding: do we ever learn?

Authors: Markus A Zeitlinger; Hartmut Derendorf; Johan W Mouton; Otto Cars; William A Craig; David Andes; Ursula Theuretzbacher
Journal: Antimicrob Agents Chemother Date: 2011-05-02 Impact factor: 5.191

3. Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.

Authors: Lorna E T Stearne; Alieke G Vonk; Bart Jan Kullberg; Inge C Gyssens
Journal: Antimicrob Agents Chemother Date: 2005-09 Impact factor: 5.191

4. A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.

Authors: Inge C Gyssens; Matthew Dryden; Peter Kujath; Dilip Nathwani; Nicolaas Schaper; Barbara Hampel; Peter Reimnitz; Jeff Alder; Pierre Arvis
Journal: J Antimicrob Chemother Date: 2011-09-06 Impact factor: 5.790

The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

Review 1. Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.

Review 2. Protein binding: do we ever learn?

3. Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.

4. A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.

Review 5. Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.

Review 6. Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.

7. Moxifloxacin in the treatment of skin and skin structure infections.